Risk factor, monitoring, and treatment for snakebite induced coagulopathy: a multicenter retrospective study

다국어 초록 (Multilingual Abstract)

Background: Snakebite can cause various complications, including coagulopathy. The clinical features of snakebite-associated coagulopathy differ from those of disseminated intravascular coagulation (DIC) caused by other diseases and its treatment is controversial.
Methods: We retrospectively reviewed the medical records of patients hospitalized for snakebite between January 2006 and September 2018.
Results: A total of 226 patients were hospitalized due to snakebite. Their median hospital stay was 4.0 days (interquartile range, 2.0 to 7.0 days). Five patients arrived at hospital with shock and one patient died. Twenty-one patients had overt DIC according to the International Society of Thrombosis and Hemostasis scoring system. Two patients developed major bleeding complications. Initial lower cholesterol level at presentation was associated with the development of overt DIC. International normalization ratio (INR) exceeding the laboratory’s measurement limit was recorded as late as 4 to 5 days after the bite. Higher antivenom doses (≥18,000 units) and transfusion of fresh frozen plasma (FFP) or cryoprecipitate did not affect prolonged INR duration or hospital stay in the overt DIC patients without bleeding.
Conclusions: Initial lower cholesterol level may be a risk factor for overt DIC following snakebite. Although patients lack apparent symptoms, the risk of coagulopathy should be assessed for at least 4 to 5 days following snakebite. Higher antivenom doses and transfusion of FFP or cryoprecipitate may be unbeneficial for coagulopathic patients without bleeding.

참고문헌 (Reference)

1 임훈, "한국 뱀 교상에 대한 항뱀독소" 대한의사협회 56 (56): 1091-1103, 2013

2 이병준, "한국 독사교상의 혈액응고장애 특성 및 항사독소 사용의 효율성" 대한외과학회 72 (72): 18-26, 2007

3 World Health Organization, "Venomous snakes distribution and species risk categories [Internet]" World Health Organization

4 Kasturiratne A, "The global burden of snakebite : a literature analysis and modelling based on regional estimates of envenoming and deaths" 5 : e218-, 2008

5 Jelinek GA, "The effect of adjunctive fresh frozen plasma administration on coagulation parameters and survival in a canine model of antivenom-treated brown snake envenoming" 33 : 36-40, 2005

6 Lu Q, "Snake venoms and hemostasis" 3 : 1791-1799, 2005

7 White J, "Snake venoms and coagulopathy" 45 : 951-967, 2005

8 Ramos OH, "Snake venom metalloproteases : structure and function of catalytic and disintegrin domains" 142 : 328-346, 2006

9 McCleary RJ, "Snake bites and hemostasis/thrombosis" 132 : 642-646, 2013

10 Warrell DA, "Snake bite" 375 : 77-88, 2010

11 Isbister GK, "Procoagulant snake toxins : laboratory studies, diagnosis, and understanding snakebite coagulopathy" 35 : 93-103, 2009

12 Mion G, "Hemostasis dynamics during coagulopathy resulting from Echis envenomation" 76 : 103-109, 2013

13 Berling I, "Hematologic effects and complications of snake envenoming" 29 : 82-89, 2015

14 Slagboom J, "Haemotoxic snake venoms : their functional activity, impact on snakebite victims and pharmaceutical promise" 177 : 947-959, 2017

15 Levi M, "Guidelines for the diagnosis and management of disseminated intravascular coagulation : British Committee for Standards in Haematology" 145 : 24-33, 2009

16 Tibballs J, "Fresh frozen plasma after brown snake bite: helpful or harmful?" 33 : 13-15, 2005

17 Isbister GK, "Failure of antivenom to improve recovery in Australian snakebite coagulopathy" 102 : 563-568, 2009

18 Isbister GK, "Factor deficiencies in venom-induced consumption coagulopathy resulting from Australian elapid envenomation:Australian Snakebite Project (ASP-10)" 8 : 2504-2513, 2010

19 Shim JH, "Ecological study on poisonous snake and investigation of the venom characteristics, snakebiting frequency in Korea" 12 : 58-77, 1998

20 Winkler E, "Decreased serum cholesterol level after snake bite(Vipera palaestinae)as a marker of severity of envenomation" 121 : 774-778, 1993

21 Maduwage K, "Current treatment for venom-induced consumption coagulopathy resulting from snakebite" 8 : e3220-, 2014

22 Jae Seok Kim, "Coagulopathy in patients who experience snakebite" 대한내과학회 23 (23): 94-99, 2008

23 Churchman A, "Clinical effects of red-bellied black snake (Pseudechis porphyriacus) envenoming and correlation with venom concentrations: Australian Snakebite Project (ASP-11)" 193 : 696-700, 2010

24 Isbister GK, "Antivenom efficacy or effectiveness : the Australian experience" 268 : 148-154, 2010

25 Isbister GK, "A randomized controlled trial of fresh frozen plasma for coagulopathy in Russell’s viper (Daboia russelii) envenoming" 15 : 645-654, 2017